Trial Profile
The HIV Second-Line Therapy AntiRetroviral Study in Patients Who Failed NNRTI-Based Regimens.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 20 Jul 2020
Price :
$35
*
At a glance
- Drugs Lopinavir/ritonavir (Primary) ; Emtricitabine/tenofovir disoproxil fumarate; Lamivudine; Tenofovir disoproxil fumarate
- Indications HIV infections
- Focus Adverse reactions; Therapeutic Use
- Acronyms HIV-STAR
- 03 Jul 2013 Results on predictors of renal insufficiency presented at the 7th International AIDS Society Conference on HIV Pathogenesis and Treatment.
- 06 Mar 2013 Results presented at the 20th Conference on Retroviruses and Opportunistic Infections.
- 08 Mar 2012 Substudy assessing neurocognitive impairment outcomes presented at the 19th Conference on Retroviruses and Opportunistic Infections.